Fundz

Innocan Pharma Corp reported raising $6.61 Million in an initial SEC Form D filing, from an offering of $6.61 Million

PUBLIC · INNPFOct 26, 2021

Amount Raised

$6.61 Million

$6.61 Million sold, per SEC Form D (first sale Oct 26, 2021)

Round Type

Venture

HerzliyaBiotechnologyHealth CarePharmaceuticalpharmaceuticals

Who to call at INNOCAN PHARMA Corp, and when

A new round usually means INNOCAN PHARMA Corp is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day INNOCAN PHARMA Corp raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at INNOCAN PHARMA Corp, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at INNOCAN PHARMA Corp. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

INNOCAN PHARMA Corp

Location

1015, 926 - 5 AVENUE SW

Herzliya, Tel Aviv, Israel

About

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. (ii) CLX CBD-loaded exosomes platform that may hold the potential to provide a highly synergistic effect of regenerating and anti- inflammatory properties targeting the Central Nervous System (CNS). In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment INNOCAN PHARMA Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoshua, Corporate Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for INNOCAN PHARMA Corp's next move

See what Strategic adds

INNOCAN PHARMA Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.